This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Intuitive Surgical (ISRG) Gains Following Q1 Earnings Beat
by Zacks Equity Research
Intuitive Surgical's (ISRG) first-quarter results reflect healthy demand for procedures, partially offset by unfavorable currency. COVID-19 impacts procedure volume in China.
Intuitive Surgical, Inc. (ISRG) Reports Q1 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for Intuitive Surgical, Inc. (ISRG) give a sense of how its business performed in the quarter ended March 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Intuitive Surgical, Inc. (ISRG) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) delivered earnings and revenue surprises of 3.36% and 6.88%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Is Intuitive Surgical (ISRG) A Buy Ahead of Q1 Earnings Announcement?
by Bryan Hayes
ISRG has missed the mark on earnings in two of the past four quarters.
TMO vs. ISRG: Which Stock Is the Better Value Option?
by Zacks Equity Research
TMO vs. ISRG: Which Stock Is the Better Value Option?
3 Medical Stocks With Solid Growth Potential to Keep Track Of
by Indrajit Bandyopadhyay
Here we discuss three medical stocks - AXSM, MRNA and ISRG - that have the potential to create wealth for investors over the coming years.
Intuitive Surgical (ISRG) to Post Q1 Earnings: What's in Store?
by Zacks Equity Research
Intuitive Surgical's (ISRG) first-quarter results likely to reflect solid performance in the Instruments & Accessories segment. However, rising costs may have hurt margins.
Is SPDR S&P Health Care Equipment ETF (XHE) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for XHE
Intuitive Surgical, Inc. (ISRG) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Intuitive Surgical, Inc. (ISRG) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) closed at $258.94 in the latest trading session, marking a +0.79% move from the prior day.
Here's Why You Should Retain Intuitive Surgical (ISRG) Stock Now
by Zacks Equity Research
Investors continue to be optimistic about Intuitive Surgical (ISRG) owing to its strength in robotics.
Zacks Investment Ideas feature highlights: Nvidia, United Healthcare, Merck, Pfizer and Intuitive Surgical
by Zacks Equity Research
Nvidia, United Healthcare, Merck, Pfizer and Intuitive Surgical are part of the Zacks Investment Ideas article.
3 Reasons to Buy Healthcare Stocks in the Current Market Environment
by Andrew Rocco
Healthcare stocks are currently providing investors with an attractive way to counterbalance a portfolio overexposed to tech. In general, healthcare stocks have lower betas, are more defensive, and have cleaner balance sheets.
Intuitive Surgical, Inc. (ISRG) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) closed at $254.71 in the latest trading session, marking a +0.47% move from the prior day.
Intuitive Surgical, Inc. (ISRG) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Intuitive Surgical, Inc. (ISRG) closed at $250.76, marking a +0.51% move from the previous day.
Intuitive Surgical, Inc. (ISRG) Stock Jumps 4.9%: Will It Continue to Soar?
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Intuitive Surgical, Inc. (ISRG) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Intuitive Surgical, Inc. (ISRG) closed at $244.47, marking a +1.52% move from the previous day.
Should You Invest in the SPDR S&P Health Care Equipment ETF (XHE)?
by Zacks Equity Research
Sector ETF report for XHE
ALC vs. ISRG: Which Stock Is the Better Value Option?
by Zacks Equity Research
ALC vs. ISRG: Which Stock Is the Better Value Option?
Intuitive Surgical, Inc. (ISRG) Stock Moves -0.47%: What You Should Know
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) closed at $234.18 in the latest trading session, marking a -0.47% move from the prior day.
Intuitive Surgical, Inc. (ISRG) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) closed the most recent trading day at $231.09, moving +0.16% from the previous trading session.
Intuitive Surgical, Inc. (ISRG) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) closed at $228.90 in the latest trading session, marking a +0.69% move from the prior day.
ALC vs. ISRG: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
ALC vs. ISRG: Which Stock Is the Better Value Option?
Intuitive Surgical, Inc. (ISRG) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) closed the most recent trading day at $231.05, moving -1.64% from the previous trading session.
Is SPDR S&P Health Care Equipment ETF (XHE) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for XHE